Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Infections with hepatitis B, C, and D virus (HBV, HCV, and HDV) are a major public health problem and lead to serious complications such as cirrhosis and hepatocellular carcinoma. We aimed to determine the seroprevalence of hepatitis B surface antigen (HBsAg), anti-HCV, anti-HDV immunoglobulin G, alpha-fetoprotein (AFP), and dual and triple hepatitis virus infections in Mongolia. Methods: A total of 2313 participants from urban and rural regions were randomly recruited for this cross-sectional study. A questionnaire was used to identify the risk factors for hepatitis virus infections, and the seromarkers were measured using immunoassay kits. Results: Among all participants, the prevalence of HBV, HCV, and HDV was 15.6%, 36.6%, and 14.3%, respectively. The infection rates were significantly higher in females and participants with a lower education level, rural residence, older age, and a history of blood transfusion. HBV and HCV co-infection was found in 120 (5.2%) participants and HBV, HCV, and HDV triple infection was detected in 67 (2.9%) participants. The prevalence of elevated AFP was 2.7%, 5.5%, and 2.6% higher in participants who were seropositive for HBsAg (p=0.01), anti-HCV (p<0.001), and anti-HDV (p=0.022), respectively. Elevated AFP was more prevalent in participants co-infected with HBV and HCV (5.8%, p=0.023), HBV and HDV (6.0%, p<0.001), and triple-infected with HBV, HCV, and HDV (7.5%) than in uninfected individuals. Conclusions: Nearly half (49.8%) of the study population aged ≥40 years were infected with HBV, HCV, or HDV, and 22.4% had dual or triple infections.
Abstract
Objectives: Infections with hepatitis B, C, and D virus (HBV, HCV, and HDV) are a major public health problem and lead to serious complications such as cirrhosis and hepatocellular carcinoma. We aimed to determine the seroprevalence of hepatitis B surface antigen (HBsAg), anti-HCV, anti-HDV immunoglobulin G, alpha-fetoprotein (AFP), and dual and triple hepatitis virus infections in Mongolia. Methods: A total of 2313 participants from urban and rural regions were randomly recruited for this cross-sectional study. A questionnaire was used to identify the risk factors for hepatitis virus infections, and the seromarkers were measured using immunoassay kits. Results: Among all participants, the prevalence of HBV, HCV, and HDV was 15.6%, 36.6%, and 14.3%, respectively. The infection rates were significantly higher in females and participants with a lower education level, rural residence, older age, and a history of blood transfusion. HBV and HCV co-infection was found in 120 (5.2%) participants and HBV, HCV, and HDV triple infection was detected in 67 (2.9%) participants. The prevalence of elevated AFP was 2.7%, 5.5%, and 2.6% higher in participants who were seropositive for HBsAg (p=0.01), anti-HCV (p<0.001), and anti-HDV (p=0.022), respectively. Elevated AFP was more prevalent in participants co-infected with HBV and HCV (5.8%, p=0.023), HBV and HDV (6.0%, p<0.001), and triple-infected with HBV, HCV, and HDV (7.5%) than in uninfected individuals. Conclusions: Nearly half (49.8%) of the study population aged ≥40 years were infected with HBV, HCV, or HDV, and 22.4% had dual or triple infections.
참고문헌 (34)
- Alcorn T, "Mongolia’s struggle with liver cancer", Lancet, 377(9772), pp.1139~1140 (2011)
- Chimed T, "Cancer incidence and cancer control in Mongolia : results from the National Cancer Registry 2008-12", Int J Cancer, 140(2), pp.302~309 (2017)
- Yan YP, "Epidemiology of hepatitis B virus infection in China : current status and challenges", J Clin Transl Hepatol, 2(1), pp.15~22 (2014)
- Muljono DH, "Epidemiology of hepatitis B and C in Republic of Indonesia", Euroasian J Hepatogastroenterol, 7(1), pp.55~59 (2017)
- Pak SC, "Viral hepatitis in South Korea", Euroasian J Hepatogastroenterol, 7(2), pp.163~165 (2017)
- Seeger C, "Hepatitis B virus biology", Microbiol Mol Biol Rev, 64(1), pp.51~68 (2000)
- Kim CW, "Hepatitis C virus : virology and life cycle", Clin Mol Hepatol, 19(1), pp.17~25 (2013)
- Liang TJ, "Hepatitis B: the virus and disease", Hepatology, 49(5 Suppl), pp.S13~S21 (2009)
- Li HC, "Hepatitis C virus: virology, diagnosis and treatment", World J Hepatol, 7(10), pp.1377~1389 (2015)
- Negro F, "Hepatitis D virus coinfection and superinfection", Cold Spring Harb Perspect Med, 4(11), pp.a021550~ (2014)
- "Global hepatitis report 2017"[URL]
- Konstantinou D, "The spectrum of HBV", HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management, 2015, pp.28(2), 221~228
- Sultana C, "Serum alpha fetoprotein, a surrogate marker for liver disease progression in chronic hepatitis C", Roum Arch Microbiol Immunol, 73(3-4), pp.69~73 (2014)
- Nelson PK, "Global epidemiology of hepatitis B and hepatitis C in people who inject drugs : results of systematic reviews", Lancet, 378(9791), pp.571~583 (2011)
- Davaalkham D, "Prevalence and risk factors for hepatitis C virus infection in Mongolian children : findings from a nationwide survey", J Med Virol, 78(4), pp.466~472 (2006)
- Kim YA, "Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia : results from a survey of Mongolian physicians from all major provinces of Mongolia", BMJ Open Gastroenterol, 3(1), pp.e000119~ (2016)
- Davaalkham D, "Hepatitis delta virus infection in Mongolia: analyses of geographic distribution, risk factors, and disease severity", Am J Trop Med Hyg, 75(2), pp.365~369 (2006)
- Delgersaikhan Zulkhuu ON, "Prevalence of HDV infection in Mongolia", Falk Symposium 199 (2015), Karger
- Baatarkhuu O, "Viral hepatitis and liver diseases in Mongolia", Euroasian J Hepatogastroenterol, 7(1), pp.68~72 (2017)
- Minekawa T, "Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants", Clin Vaccine Immunol, 20(8), pp.1255~1265 (2013)
- Inoue J, "High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia", J Med Virol, 76(3), pp.333~340 (2005)
- Nomura M, "A pitfall in two-site sandwich ‘one-step’ immunoassay with monoclonal antibodies for the determination of human alpha-fetoprotein", J Immunol Methods, 56(1), pp.13~17 (1983)
- Tserenpuntsag B, "Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors", Transfusion, 50(1), pp.92~99 (2010)
- Tsatsralt-Od B., "Viral hepatitis in Mongolia: past, present, and future", Euroasian J Hepatogastroenterol, 6(1), pp.56~58 (2016)
- Davaalkham D, "Impact of the universal hepatitis B immunization program in Mongolia : achievements and challenges", J Epidemiol, 17(3), pp.69~75 (2007)
- Moore KJ, "Prevalence and sociodemographic disparities of hepatitis C in baby boomers and the US adult population", J Infect Public Health, 12(1), pp.32~36 (2019)
- Chlibek R, "Prevalence of hepatitis C virus in adult population in the Czech Republic-time for birth cohort screening", PLoS One, 12(4), pp.e0175525~ (2017)
- Chen HY, "Prevalence and burden of hepatitis D virus infection in the global population : a systematic review and meta-analysis", Gut, 68(3), pp.512~521 (2019)
- Tsatsralt-Od B, "High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia", J Med Virol, 77(4), pp.491~499 (2005)
- Kitab B, "Occult HBV infection in Morocco : from chronic hepatitis to hepatocellular carcinoma", Liver Int, 34(6), pp.e144~e150 (2014)
- Baatarkhuu O, "Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia : a population-based nationwide study", Liver Int, 28(10), pp.1389~1395 (2008)
- Tosun S, "The impact of economic and social factors on the prevalence of hepatitis B in Turkey", BMC Public Health, 18(1), pp.649~ (2018)
- Yaseen MR, "Socio-economic factors affecting hepatitis C and lack of awareness : a case study of Pakistan", Iran J Public Health, 43(10), pp.1456~1457 (2014)
- Konstantinou D, "The spectrum of HBV", HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management, 2015, pp.28(2), 221~228